Differential Expression of mRNAs in Peripheral Blood Related to Prodrome and Progression of Alzheimer’s Disease

Abstract EN

Alzheimer’s disease (AD) is a chronic progressive neurodegenerative disease that affects the quality of life of elderly individuals, while the pathogenesis of AD is still unclear.

Based on the bioinformatics analysis of differentially expressed genes (DEGs) in peripheral blood samples, we investigated genes related to mild cognitive impairment (MCI), AD, and late-stage AD that might be used for predicting the conversions.

Methods.

We obtained the DEGs in MCI, AD, and advanced AD patients from the Gene Expression Omnibus (GEO) database.

A Venn diagram was used to identify the intersecting genes.

Gene Ontology (GO) and Kyoto Gene and Genomic Encyclopedia (KEGG) were used to analyze the functions and pathways of the intersecting genes.

Protein-protein interaction (PPI) networks were constructed to visualize the network of the proteins coded by the related genes.

Hub genes were selected based on the PPI network.

Results.

Bioinformatics analysis indicated that there were 61 DEGs in both the MCI and AD groups and 27 the same DEGs among the three groups.

Using GO and KEGG analyses, we found that these genes were related to the function of mitochondria and ribosome.

Hub genes were determined by bioinformatics software based on the PPI network.

Conclusions.

Mitochondrial and ribosomal dysfunction in peripheral blood may be early signs in AD patients and related to the disease progression.

The identified hub genes may provide the possibility for predicting AD progression or be the possible targets for treatments.